V012-1926 Screening compound: N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide

V012-1926 Screening compound: N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide
V012-1926 Screening compound: N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-1926
N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-1926

Molecular Formula

C21H19F4N3O (C21 H19 F4 N3 O)

Compound Name

N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide

IUPAC name

N-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-fluoro-5-(trifluoromethyl)benzamide

SMILES

CC(C)(C)c(cc1NC(c2cc(C(F)(F)F)cc(F)c2)=O)nn1-c1ccccc1

InChI

InChI=1S/C21H19F4N3O/c1-20(2,3)17-12-18(28(27-17)16-7-5-4-6-8-16)26-19(29)13-9-14(21(23,24)25)11-15(22)10-13/h4-12H,1-3H3,(H,26,29)

InChI Key

KXVITZPXPRUUEY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19949999

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

405.4

Hydrogen Bond Acceptors Count

3.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

6.014

Distribution Coefficient, logD

5.923

Water Solubility, LogSw

-5.59

Polar Surface Area

37.765

Acid Dissociation Constant (pKa)

8.04

Base Dissociation Constant (pKb)

-1.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.80

V012-1926 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with V012-1926 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-1926?
Check Price and Availability of V012-1926, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-1926 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-1926
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-1926
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-1926 available by request